» Articles » PMID: 1305472

Thyroid Hormones and Duration of Ovulatory Activity in the Etiology of Breast Cancer

Overview
Date 1992 Jul 1
PMID 1305472
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

We conducted the present study with the hypothesis that conflicting reports on the association between mild hypothyroidism and breast cancer may be due to failure to consider the potential interaction between thyroid and ovarian hormones. Seventy-three cases of breast cancer and 75 hospital controls were studied. The overall matched multivariate odds ratio of breast cancer for the lowest tertile of free T4 (< or = 1.10 ng/dl) versus the two other tertiles was 1.7 (95% confidence limits, 0.6-5.0). However, there was a statistically significant linear trend (P = 0.04) in the odds ratios for breast cancer related to subnormal free T4 levels across tertiles of duration of ovulatory activity. These results suggest that women combining low levels of circulating free T4 with long duration of ovulatory activity may be at increased risk for this disease.

Citing Articles

Malignant neoplasms in people with hypothyroidism in Spain: A population-based analysis.

Diez J, Iglesias P PLoS One. 2022; 17(10):e0275568.

PMID: 36197930 PMC: 9534429. DOI: 10.1371/journal.pone.0275568.


The TSH/Thyroid Hormones Axis and Breast Cancer.

Voutsadakis I J Clin Med. 2022; 11(3).

PMID: 35160139 PMC: 8836919. DOI: 10.3390/jcm11030687.


Breast Cancer Risk in Postmenopausal Women with Medical History of Thyroid Disorder in the Women's Health Initiative.

Weng C, Okawa E, Roberts M, Park S, Umbricht C, Manson J Thyroid. 2020; 30(4):519-530.

PMID: 31918623 PMC: 7187984. DOI: 10.1089/thy.2019.0426.


Thyroid disorders and breast cancer risk in Asian population: a nationwide population-based case-control study in Taiwan.

Weng C, Chen Y, Lin C, Luo X, Lin T BMJ Open. 2018; 8(3):e020194.

PMID: 29602850 PMC: 5884336. DOI: 10.1136/bmjopen-2017-020194.


Does thyroid dysfunction increase the risk of breast cancer? A systematic review and meta-analysis.

Fang Y, Yao L, Sun J, Yang R, Chen Y, Tian J J Endocrinol Invest. 2017; 40(10):1035-1047.

PMID: 28516372 DOI: 10.1007/s40618-017-0679-x.